Expansion Therapeutics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Out of Business

  • Employees
  • 24

Employees

  • Latest Deal Type
  • Out of Business

Expansion Therapeutics General Information

Description

Provider of small molecule binders transformative oral medicines intended to treat severe RNa-mediated diseases. The company's technology is a portfolio of novel RNA-targeted drug candidates with activity across a broad number of disease indications, enabling medical companies to provide treatment options for patients.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 555 Heritage Drive
  • Suite 150
  • Jupiter, FL 33458
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 555 Heritage Drive
  • Suite 150
  • Jupiter, FL 33458
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Expansion Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 20-Oct-2022 Completed Out of Business
3. Later Stage VC (Series B) 29-Sep-2021 Completed Generating Revenue
2. Early Stage VC (Series A) 03-Jan-2018 $5M $5M Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Expansion Therapeutics’s complete valuation and funding history, request access »

Expansion Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Expansion Therapeutics’s complete cap table history, request access »

Expansion Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of small molecule binders transformative oral medicines intended to treat severe RNa-mediated diseases. The com
Drug Discovery
Jupiter, FL
24 As of 2025

South San Francisco, CA
 

Niel, Belgium
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Expansion Therapeutics Competitors (38)

One of Expansion Therapeutics’s 38 competitors is NGM Biopharmaceuticals, a Private Equity-Backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NGM Biopharmaceuticals Private Equity-Backed South San Francisco, CA
etherna Formerly VC-backed Niel, Belgium
Sarepta Therapeutics Formerly VC-backed Cambridge, MA
Sangamo Therapeutics Formerly VC-backed Richmond, CA
Senti Biosciences Holdings Formerly VC-backed South San Francisco, CA
You’re viewing 5 of 38 competitors. Get the full list »

Expansion Therapeutics Patents

Expansion Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4210703-A1 Small molecules that target the rna that causes als Pending 08-Sep-2020
EP-4210703-A4 Small molecules that target the rna that causes als Pending 08-Sep-2020
US-20240067639-A1 Small molecules that target the rna that causes als Pending 08-Sep-2020
WO-2022055922-A1 Small molecules that target the rna that causes als Inactive 08-Sep-2020
US-20200207744-A1 Dimer compounds, and use in binding toxic repeats of rna Inactive 28-Dec-2018 C07D235/18
To view Expansion Therapeutics’s complete patent history, request access »

Expansion Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Expansion Therapeutics FAQs

  • When was Expansion Therapeutics founded?

    Expansion Therapeutics was founded in 2016.

  • Where is Expansion Therapeutics headquartered?

    Expansion Therapeutics is headquartered in Jupiter, FL.

  • What is the size of Expansion Therapeutics?

    Expansion Therapeutics has 24 total employees.

  • What industry is Expansion Therapeutics in?

    Expansion Therapeutics’s primary industry is Drug Discovery.

  • Is Expansion Therapeutics a private or public company?

    Expansion Therapeutics is a Private company.

  • What is Expansion Therapeutics’s current revenue?

    The current revenue for Expansion Therapeutics is .

  • How much funding has Expansion Therapeutics raised over time?

    Expansion Therapeutics has raised $85M.

  • Who are Expansion Therapeutics’s competitors?

    NGM Biopharmaceuticals, etherna, Sarepta Therapeutics, Sangamo Therapeutics, and Senti Biosciences Holdings are some of the 38 competitors of Expansion Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process